Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Vor Biopharma Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18
Revenues31.66.22.4
            Revenue growth410.0%154.8% 
Cost of goods sold63.212.42.9
Gross profit-31.6-6.2-0.4
            Gross margin-100.0%-100.0%-17.6%
General and administrative11.74.20.4
EBIT-43.4-10.4-2.9
            EBIT margin-137.2%-168.0%-117.6%
Pre-tax income-49.3-12.6-4.2
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-49.3-12.6-4.2
            Net margin-155.8%-203.4%-170.7%
 
Diluted EPS($230.56)($109.71)($47.30)
Shares outstanding (diluted)0.20.10.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy